Medpace Holdings Income Statement (2015-2026) | MEDP

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	278.29M	295.57M	308.55M	330.95M	351.21M	383.74M	394.10M	434.07M	460.87M	492.50M	498.40M	511.04M	528.10M	533.32M	536.59M	558.57M	603.31M	659.90M	708.45M	706.60M
Cost of Revenue (Quarter)	203.64M	208.47M	220.57M	232.27M	252.21M	264.71M	278.37M	303.88M	336.55M	359.31M	361.60M	355.90M	374.27M	364.31M	358.27M	380.22M	423.30M	462.96M	503.13M	510.28M
Gross Profit (Quarter)	74.65M	87.09M	87.98M	98.68M	99.00M	119.03M	115.73M	130.19M	124.32M	133.19M	136.81M	155.14M	153.84M	169.01M	178.32M	178.35M	180.01M	196.94M	205.32M	196.33M
Operating items
Amortization - Intangibles (Quarter)	1.28M	1.28M	1.28M	0.84M	0.84M	0.84M	0.84M	0.55M	0.55M	0.55M	0.55M	0.36M	0.36M	0.36M	0.36M	0.24M	0.24M	0.24M	0.24M	0.15M
Depreciation & Amortization - Total (Quarter)	3.95M	4.06M	4.18M	4.27M	4.71M	4.95M	5.06M	5.41M	5.97M	6.33M	6.42M	6.63M	6.87M	7.16M	7.14M	6.69M	6.78M	6.81M	6.92M	6.75M
Selling, General & Administrative (Quarter)	26.97M	28.05M	27.66M	29.37M	33.22M	35.42M	33.40M	38.03M	39.40M	41.41M	42.51M	44.08M	41.45M	49.22M	45.43M	57.90M	46.66M	48.08M	44.92M	47.92M
Other Operating Expenses (Quarter)	204.92M	209.75M	221.85M	233.11M	253.05M	265.55M	279.20M	304.44M	337.10M	359.86M	362.14M	356.26M	374.63M	364.67M	358.64M	380.46M	423.54M	463.20M	503.35M	510.43M
Operating Expenses (Quarter)	235.84M	241.85M	253.70M	266.74M	290.97M	305.92M	317.67M	347.87M	382.48M	407.59M	411.08M	406.98M	422.95M	421.04M	411.21M	445.05M	476.98M	518.10M	555.18M	565.10M
Operating Income (Quarter)	42.45M	53.71M	54.85M	64.20M	60.24M	77.83M	76.43M	86.20M	78.39M	84.91M	87.32M	104.07M	105.15M	112.27M	125.38M	113.52M	126.33M	141.81M	153.27M	141.50M
EBIT (Quarter)	42.45M	53.71M	54.85M	64.20M	60.24M	77.83M	76.43M	86.20M	78.39M	84.91M	87.32M	104.07M	105.15M	112.27M	125.38M	113.52M	126.33M	141.81M	153.27M	141.50M
Non-operating items
Interest & Investment Income (Quarter)	-0.03M	-0.04M	-0.02M	0.05M	-0.55M	-1.58M	-0.83M	-0.86M	-1.37M	-0.10M	1.84M	4.12M	5.46M	7.53M	7.88M	6.46M	1.08M	1.52M	3.72M	5.12M
Other Non Operating Income (Quarter)	0.27M	1.06M	1.09M	1.07M	2.31M	5.65M	-1.96M	0.69M	-1.28M	-1.60M	1.54M	4.59M	-0.13M	-1.02M	0.62M	-1.82M	-2.88M	-0.49M	-0.16M	0.97M
Non Operating Income (Quarter)	0.24M	1.06M	1.17M	1.12M	2.31M	4.07M	-2.79M	-0.17M	-2.65M	-1.60M	1.54M	8.71M	-0.13M	-1.02M	-16.49M	4.65M	-1.80M	-0.49M	12.62M	6.09M
Net income details
EBT (Quarter)	42.69M	54.74M	55.92M	65.32M	62.00M	81.89M	73.64M	86.03M	75.74M	83.20M	90.71M	112.78M	110.48M	118.78M	133.88M	118.17M	124.54M	142.84M	156.83M	147.59M
Tax Provisions (Quarter)	2.75M	6.16M	5.89M	4.01M	12.64M	15.87M	4.97M	13.14M	14.68M	12.65M	12.41M	10.19M	22.13M	22.35M	16.86M	3.58M	34.28M	31.70M	21.70M	23.72M
Profit After Tax (Quarter)	39.93M	48.57M	50.03M	61.31M	49.36M	66.03M	68.67M	72.89M	61.07M	70.55M	78.30M	102.59M	88.35M	96.43M	117.02M	114.59M	90.26M	111.14M	135.13M	123.87M
Income from Continuing Operations (Quarter)	39.93M	48.57M	50.03M	61.31M	49.36M	66.03M	68.67M	72.89M	61.07M	70.55M	78.30M	102.59M	88.35M	96.43M	117.02M	114.59M	90.26M	111.14M	135.13M	123.87M
Consolidated Net Income (Quarter)	39.93M	48.57M	50.03M	61.31M	49.36M	66.03M	68.67M	72.89M	61.07M	70.55M	78.30M	102.59M	88.35M	96.43M	117.02M	114.59M	90.26M	111.14M	135.13M	123.87M
Income towards Parent Company (Quarter)	39.93M	48.57M	50.03M	61.31M	49.36M	66.03M	68.67M	72.89M	61.07M	70.55M	78.30M	102.59M	88.35M	96.43M	117.02M	114.59M	90.26M	111.14M	135.13M	123.87M
Net Income towards Common Stockholders (Quarter)	39.93M	48.57M	50.03M	61.31M	49.36M	66.03M	68.67M	72.89M	61.07M	70.55M	78.30M	102.59M	88.35M	96.43M	117.02M	114.59M	90.26M	111.14M	135.13M	123.87M
Additional items
EPS (Basic) (Quarter)	1.11	1.35	1.39	1.75	1.52	2.13	2.18	2.35	2.00	2.30	2.55	3.32	2.85	3.11	3.78	3.77	3.16	3.95	4.76	4.35
EPS (Weighted Average and Diluted) (Quarter)	1.06	1.29	1.32	1.69	1.46	2.05	2.10	2.27	1.93	2.22	2.46	3.20	2.75	3.01	3.67	3.67	3.10	3.86	4.64	4.28
Shares Outstanding (Weighted Average) (Quarter)	35.89M	35.82M	35.86M	34.92M	32.49M	32.79M	32.39M	31.01M	30.54M	30.63M	30.72M	30.84M	30.92M	30.96M	30.96M	30.39M	28.60M	28.14M	28.85M	28.45M
Shares Outstanding (Diluted Average) (Quarter)		37.52M	37.70M	36.36M	35.03M	34.10M	33.67M	32.16M	31.57M	31.76M	31.84M	32.00M	32.05M	32.09M	32.01M	31.20M	30.16M	28.82M	29.53M	28.96M
EBITDA (Quarter)	46.40M	57.77M	59.04M	68.47M	64.94M	82.78M	81.49M	91.61M	84.36M	91.24M	93.74M	110.70M	112.02M	119.43M	132.51M	120.22M	133.11M	148.62M	160.19M	148.25M
Tax Rate (Quarter)	6.45%	11.26%	10.53%	6.14%	20.39%	19.37%	6.76%	15.27%	19.38%	15.21%	13.68%	9.04%	20.03%	18.82%	12.60%	3.03%	27.52%	22.19%	13.84%	16.07%

Research Tools

Medpace Holdings Income Statement (2015-2026) | MEDP

Create an account

Sign In

Reset Password